Patent Application
20090045056
The present invention relates generally to the field of diagnostic medicine and, more specifically, to methods for producing a multiple-use biosensor for amperometric creatinine determination that includes a biopolymer of immobilized enzymes.
The determination of creatinine levels in biological fluids is an increasingly important clinical necessity. Amperometric biosensors have been developed based on a three-enzyme system which converts creatinine to amperometrically measurable hydrogen peroxide. Due to the complexity of the three-enzyme system, development of these biosensors has been slow.
Incorporation of enzymes into polymer networks through multi-point attachment is a rapid and effective general strategy for enhancing the stability of enzymes, while retaining activity. This strategy involves the production of bioplastics in a single step, employing oligomers capable of chemical reaction with specific functionalities on the enzyme surface.
The utility of enzymes in biosensors is limited by their stability. Clinical blood analyzers require enzymes to be used over and over while in contact with whole blood. Many blood analyzers operate at 37° C. which further limits enzyme stability. A variety of immobilization procedures are described in the literature for use with biosensors. Although most of the procedures described suggest utility for biosensors, they are often not tested under conditions that would be applicable under real-life conditions, such as room temperature or at 37° C. while in contact with fluid. Enzyme immobilization is especially critical for continuous use biosensors where enzyme leaching can be a concern.
Enzyme immobilization into a “biopolymer” by Multipoint covalent attachment affords a straightforward and convenient method for preparation of immobilized enzymes for biosensors. Not only does multipoint covalent immobilization prevent enzyme leaching, but it also increases enzyme stability to heat, pH, organic solvents, peroxides and proteolytic and microbial degradation.
Thus, there is a need for the development of multiple-use biosensors that have incorporated as a component stable enzymes that retain activity. The present invention meets this need and provides related advantages.
The invention provides methods for preparing a stable, multiple-use three enzyme biosensor for the amperometric determination of creatinine in biological liquids that has a useful lifetime significantly beyond that of presently available amperometric biosensors. The biosensor prepared by the methods of the invention encompasses a plurality of immobilized enzymes that are applied to the biosensor as an enzyme-polymer composition. The enzymes, which can include creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase, are immobilized into the enzyme-polymer composition simultaneously as well as applied to the biosensor simultaneously. Prior to being immobilized, the enzymes can be chemically modified by attaching one or more polyethylene glycol (PEG) chains per enzyme monomer. The polymer component can be provided by a polyurethane membrane. The invention also provides a method of preparing a biosensor that limits the diffusion of silver ions emanating the reference electrode, thereby preventing contact between the silver ions and the enzymes. Related methods of preparing an enzyme-polymer composition for incorporation into a multiple-use three enzyme biosensor for the amperometric determination of creatinine in biological liquids also are provided. The invention also provides multiple-use biosensors and enzyme-polymer compositions prepared by the methods disclosed.
The invention provides methods for preparing a stable, multiple-use three enzyme biosensor for the amperometric determination of creatinine in biological liquids that has a useful lifetime that extends significantly beyond that of presently available amperometric biosensors.
As disclosed herein, the enzymes creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase can be effectively modified and incorporated into enzyme-polymer compositions. The immobilization of the enzymes into enzyme-polymer compositions according to the methods of the invention significantly improves the enzyme stability and increases the half-life. The enzyme-polymer compositions and biosensors prepared according to the methods of the invention have considerable enzyme stability and allow for multiple-use of the biosensor extending for more than 4 days, more than 6 days, more than 8 days, more than 10 days, more than 12 days, more than 15 days, more than 20 days, more than 25 days, more than 30 days.
The biosensor prepared by the methods of the invention encompasses a plurality of immobilized enzymes that are applied to the biosensor as an enzyme-polymer composition. The enzymes, which can include creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase, can be immobilized into the enzyme-polymer composition simultaneously as well as applied to the biosensor simultaneously. In other embodiments, enzymes can be immobilized and added in a step-wise manner or any combination of desired by the user.
A critical step in the development of biosensors is effective enzyme immobilization. The invention is based, in part, on the discovery that it is possible to successfully immobilize the three enzymes used in amperometric creatinine biosensors, creatinine amidohydrolase creatine amidinohydrolase, and sarcosine oxidase, into membranes using polyurethane prepolymers while retaining sufficient enzymatic activity. As exemplified herein, the three enzymes can be covalently modified and incorporated into polyurethane hydrogels where they exhibit improved stability when compared to the native enzymes in solution at 37° C. The biosensor prepared according to the methods of the invention can be used at a temperature desired by the user and depending on the particular application, for example, at room temperature as well as at 37° C.
In a preferred embodiment, the invention provides a method for preparing a multiple-use three enzyme biosensor for the amperometric determination of creatinine in biological liquids, the biosensor containing a plurality of immobilized enzymes, the method comprising applying to the biosensor an enzyme-polymer composition comprising the plurality of immobilized enzymes.
The three-enzyme system converts creatinine to amerometrically measurable hydrogen peroxide H2O2.
It is contemplated that all three enzymes that are components of this system are immobilized in the enzyme-polymer composition. However, embodiments in which only one or two of the three enzymes are immobilized into the enzyme-polymer composition also represent useful embodiments of the invention. Thus, at least one or at least two or all three of the enzymes creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase can be immobilized into the enzyme-polymer composition that is applied to a biosensor of the invention. The enzymes can be immobilized into the enzyme-polymer composition simultaneously in a single step. Consequently, the enzymes can be applied to the biosensor simultaneously as part of a polymer sheet or membrane, for example, a polyurethane membrane.
The methods of the invention for preparing a stable, multiple-use three enzyme biosensor for the amperometric determination of creatinine in biological liquids can further include the initial step of chemically modifying the enzymes by attaching one or more polyethylene glycol (PEG) chains per enzyme monomer. The conjugation of enzyme monomers with water soluble polymeric modifiers, especially, the conjugation with polyethylene glycol (PEG), often called “PEGylation” is contemplated as an initial step. Bioconjugation of the enzyme monomers with water-soluble polymeric modifiers increases their molecular size and steric hindrance and improve the half-lives of the enzymes.
A biosensor according to the invention has at least one working, at least one reference and at least one counter electrode and has applied to its surface one, two or three of the enzymes, which have been immobilized as disclosed by the method of the invention. As disclosed herein, the enzymes can become part of the biosensor by being incorporated into an enzyme-polymer composition, for example, a polyurethane membrane, that is applied to the sensor.
If desired by the user, the sensor can have, for example, two working electrodes, each containing at least one, at least two or three immobilized enzymes. For example, one electrode may contain two of the three enzymes, while a second working electrode contains all three. Any combination and permutation of enzymes and electrodes can be selected by the used based on the desired embodiment of the invention that is to be performed. In a further embodiment, the biosensor is made up of two three-electrodes systems, the first electrode system comprising the enzymes creatinine amidohydrolase, creatine amidinohydrolase and sarcosine oxidase and serving for the determination of the sum of creatinine and creatine and the second electrode system comprising the enzymes creatine amidinohydrolase and sarcosine oxidase and serving for the determination of creatine, whereby the result of the second electrode system is deducted from the result of the first one for the determination of creatinine. If desired, the biosensor comprises a further electrode system serving for the elimination of electrochemical interferences.
Enzymes can be susceptible to inhibition by silver, which can cause inactivation even if present in micromolar quantities. Susceptibility to silver ions can be important when using the enzymes in amperometric creatinine biosensors with silver-containing electrodes. As described below, a three-enzyme-polymer applied to silver electrode bodies can cause deactivation by silver ions. For example, creatine amidinohydrolase is highly susceptible to inhibition by silver. Addition of silver scavenging thiol-containing molecules can be effective in preventing the loss of enzyme activity due to silver. Based on GNM analysis of the molecular dynamics of creatine amidinohydrolase, two of the cysteine residues, Cys60 and Cys297 in both chains were identified as important in controlling the functional dynamics of the enzyme and play a role in destabilizing the enzyme and leading to inactivation. Significantly, Cys297 is surrounded by negatively charged residues that attract positively charged silver near this residue. The use of creatine amidinohydrolase in a biosensor therefore requires protection from silver ions, which can be accomplished by utilizing a mimetic of the enzyme that has decreased silver susceptibility, adding silver scavengers or, in preferred embodiments, covering the electrode with a material that prevents contact between silver ions and the enzyme.
In view of the above it is contemplated that, in embodiments where the reference electrode is an Ag/AgCl (silver/chloride) electrode, the reference electrode can be covered with a material that limits diffusion of silver ions emanating from said reference electrode, thereby preventing contact between the silver ions and the enzymes. It is contemplated that the use of a cellulose acetate cover membrane to separate the electrode from the enzyme-polymer composition, for example, the polyurethane membrane, can slow the leaching of silver from the electrodes can improve sensor half-life. Furthermore, improvements in sensor design to prevent the leaching of silver ions and reduce enzyme contact with the sensor can be used to increase the use-life of creatinine biosensors and increase their utility in clinical whole blood analysis. Generally, an electrode in a biosensor according to the invention can consist of carbon, metal, metal oxides or a mixture of carbon and metal or metal oxides. Furthermore, it is contemplated that the electrodes are applied on a nonconducting substrate.
In a preferred embodiment, the biosensor is made up of two three-electrodes systems, the first electrode system comprising the enzymes creatininase, creatinase and sarcosine oxidase and serving for the determination of the sum of creatinine and creatine and the second electrode system comprising the enzymes creatinase and sarcosine oxidase and serving for the determination of creatine, whereby the result of the second electrode system is deducted from the result of the first one for the determination of creatinine. If desired, the biosensor can contain a further electrode for the elimination of electrochemical interferences.
The methods of the invention encompass the chemical modification and immobilization of sarcosine oxidase into an enzyme-polymer composition, also referred to as a biopolymer, for example into a polyurethane polymer. While the invention method is exemplified with polyurethane, the skilled person will appreciate that any polymer that allows for incorporation of the enzymes into the polymer network in a manner that enhances the stability of the enzymes, while retaining activity, is contemplated as useful for practicing the methods of the invention, for example, polyurethane, cyanate polymers, polyvinyl chloride, polyester, polycarbonate, vinyl acetate copolymer, nylon, poly(1,4-butleneterephthalate), cellulose propionate, ethylene/acrylic acid copolymer, polybutadiene, polyethylene, polypropylene, polyimide, acrylic film, polystyrene, and polyvinyl fluoride.
In a preferred embodiment, the methods provided herein encompass the production of an enzyme-polymer composition is performed in a single step, employing oligomers capable of chemical reaction with specific functionalities on the enzyme surface. The enzymes are attached to the polymer in a manner that provides protein retention, for example, by means of crosslinking, covalent binding or matrix inclusion, so that the advantages of immobilization can be maximized.
The invention is based, in part, on the discovery of the particular structure-function-environment relationship required to maintain sarcosine oxidase in a polymeric sensor environment. Sarcosine oxidase (EC 1.5.3.1) catalyzes the oxidative demethylation of sarcosine (N-methylglycine) and forms equimolar amounts of formaldehyde, glycine, and hydrogen peroxide. Sarcosine oxidase from the Arthrobacter sp. is a monomer with a molecular weight of 43 kDa (Nishiya and Imanaka, J Ferm Bioeng 75:139-244 (1993)). The monomeric sarcosine oxidases (MSOX) are flavine proteins that contain mole of flavine adenine dinucleotide (FAD) that is covalently linked to the enzyme by a cysteine residue (Trickey et al., Structure 7:331-345 (1999)). In certain embodiments the enzyme sarcosine oxidase is contacted with an inhibitor, for example, pyrrole-2-carboxylic acid or (methylthio)acetic acid, in an amount effective to prevent inactivation during the chemical modification step. As described herein, sarcosine oxidase was inactivated when modified by a single molecule of PEG-NCO and it was discovered that two irreversible inhibitors, (methylthio)acetic acid and pyrrole-2-carboxylic acid, were effective in preventing enzyme inactivation during modification allowing the enzyme to be successfully and irreversibly immobilized during polymerization by chemical crosslinking into polyurethane hydrogel-forming polymers, retaining activity and stability sufficient for use of approximately 30 days in a buffered solution at 37° C.
Creatine amidinohydrolase (creatinase, EC 3.5.3.3) is a homodimer with subunit molecular weights of approximately 45 kDa. The two active sites of the protein are at the interface of the monomers being shared by each monomer and only the dimer is active. While the enzyme has a low functional stability, additives such as reducing agents, proteins and polyols have been shown to increase the stability of the enzyme (Schumann et al., Biol Chem 374:427-434 (1993a)). The low intrinsic stability of creatinase has prompted the use of protein engineering to improve stability (Schumann, et al., Protein Science 2:1612-1620 (1993b)). As disclosed herein, creatine amidinohydrolase can be effectively modified by PEG-NCO and covalently incorporated into polyurethane materials via modification by isocyanate prepolymers. Creatine amidinohydrolase was successfully and irreversibly immobilized by chemical crosslinking into polyurethane polymers and retained significant activity and sufficient stability to be used for 30 days in a buffered solution at 37° C.
The following examples are intended to illustrate, but not to limit the invention.
This example describes the immobilization of sarcosine oxidase in polyurethane polymers using PEG-NCO.
Sarcosine oxidase (from Arthrobacter sp., SAO-341) was purchased from Toyobo Co., Ltd. Horseradish peroxidase was purchase from Sigma-Aldrich (St. Louis, Mo.). All enzymes were used without further purification. PEG-NCO (Mw 5 000) and PEGSPA (Mw 5,000) were obtained from Shearwater Polymers Inc. (Huntsville, Ala.). Hypol 2060G prepolymer was purchased from Hampshire Chemical (Lexington, Mass.). All other reagents were purchased from Sigma-Aldrich Chemicals (St. Louis, Mo.) and were of the highest purity available.
Sarcosine oxidase was dissolved in an aqueous buffer (50 mM phosphate buffer, pH 7.5 or 50 mM borate buffer, pH 8.5) at a concentration of 1 mg/mL. PEG NCO or PEG-SPA was added in excess to the enzyme at a molar ratio of 1:100 to ensure complete enzyme modification. In some experiments sarcosine oxidase inhibitors (50 mM methylthioacetic acid or 50 mM pyrrole-2-caroxylic acid) were added to help prevent inactivation of the enzyme. The reaction mixture was mixed for 30 min followed by dialysis (12 000 Mw cutoff) against 50 mM phosphate buffer (Drevon et al., Biomacromolecules 2:764-771 (2001)).
Hypol prepolymer 2060G (0.4 g), a toluene diisocyanate based prepolymer, was added to a buffered solution (3.6 g of 50 mM phosphate buffer, 50 mM inhibitor, pH 7.5 containing sarcosine oxidase (0 to 200 units enzyme per gram of prepolymer). The aqueous polymer solution was vigorously mixed for 30 s in a weigh boat until the onset of gelation. Polymerization was very rapid and gelation usually took place within one minute.
MALDI-MS analyses were performed using a Perspective Biosystems Voyager Elite MALDI-TOF. The acceleration voltage was set- to 20 kV in a linear mode. 1 μL of PEGylated enzyme solution (0.1 mg/mL) was mixed with 1 ÿL of matrix solution (0.5 mL water, 0.5 mL of acetonitrile, 1 μL of trifluoracetic acid, and 10 mg of sinapinic acid) and then spotted on the target plate. Spectra were recorded after evaporation of the solvent mixture and were calibrated externally with equine cytochrome C (12,361.96 Da (ave)), rabbit muscle aldolase (39,212.28 Da (ave)) and bovine serum albumin (66,430.09 Da (ave)).
The production of hydrogen peroxide was measured by using the 4-aminoantipyrene-peroxidase system (Nishiya and Imanaka, Appl. Environ. Microbiol. 62:2405-2410 (1996)). Typically, an enzyme solution (0.05 mL) was incubated with a mixture (1.0 mL total) of 95 mM sarcosine, 0.47 mM 4-aminoantipyrene, 2 mM phenol, 0.045% Triton X-100, 50 mM sodium phosphate (pH 8.0) and 5 units/mL of horseradish peroxidase at 37° C. for 10 minutes. The reaction was terminated by addition of 2.0 mL of 0.25% SDS solution and the absorbance at 500 nm was measured. One unit was defined as the amount of enzyme that catalyzed the oxidation of 1). mol of substrate per minute.
The initial rate of oxygen consumption was also measured at 37° C. with a Clark oxygen electrode from Yellow Springs Instruments (Yellow Springs, Ohio). The reaction was initiated by adding an enzyme solution (1 μL) or an enzyme-containing polymer (10-100 mg cut into small pieces) to 5.0 mL of substrate (50 mM sarcosine in 50 mM phosphate buffer, pH 7.5). Before measurement, the assay solution was allowed to equilibrate to 37° C. with air. Oxygen consumption was measured for 5 to 10 minutes.
Sarcosine oxidase was added to a buffered medium (50 mM sodium phosphate, 2 mM EDTA, pH 7.5). The native enzyme concentration used was 0.06 mg/ml. The activity of sarcosine oxidase was followed over time at room temperature (22° C.), and at 4° C. and 37° C. using the end point assay described above.
Thermoinactivation of PEG-sarcosine oxidase was monitored at 37° C. in buffer (50 mM sodium phosphate, 2 mM EDTA, pH 7.5) as described for the native enzyme. The enzyme concentration in all samples was adjusted to 0.05 mg/ml.
Enzyme polymer samples were cut into small pieces and added to buffer (50 mM phosphate, pH 7.5) and incubated at 37° C. Samples were removed over time and assayed for enzymatic activity using the oxygen electrode.
To determine the effect of silver ions on sarcosine oxidase, 0.07 mg/mL sarcosine oxidase were incubated in 20 mM Tris-HCl (pH 7.5) with silver nitrate (0 to 1 mM) at room temperature. Samples were removed periodically and assayed using the end point assay for sarcosine oxidase activity.
Effect of PEGylation on Enzyme Activity and Stability
Since immobilization of the enzyme into polyurethane polymers involves chemical modification of the enzyme by reactions involving isocyanate with nucleophilic residues on the enzyme surface it is convenient to model the process of chemical modification using soluble polymers. Modification using this technique allows us to mimic the effect of covalent immobilization on enzyme activity while still working with a soluble enzyme. Once the enzyme is incorporated into a polymer, mass transfer effects can complicate the analysis.
Monomeric sarcosine oxidase was modified using PEG-NCO (5,000 MW) at pH 7.5 (50 mM phosphate buffer) and pH 8.5 (50 mM borate buffer) using different ratios (NCO/enzyme). The amount of native enzyme remaining was quantified using MALDI-TOF analysis and plotted versus the activity retention of sarcosine oxidase following modification (
Since a single modification by isocyanate appeared to deactivate sarcosine oxidase, a method will be required to protect the enzyme during immobilization within polyurethane polymers. If modification is occurring at or near an active site residue, an inhibitor can be added to solution to help increase activity retention by blocking the active site cleft. Although this method of protection is often discussed, the literature contains precious few examples of where inhibitor protection strategies work effectively. A number of inhibitors have been identified for sarcosine oxidase (Wagner et al., Biochem 39:8813-8824 (2000)). Pyrrole-2-carboxylic acid (Ki=1.37 mM) and (methylthio)acetic acid (Ki=2.60 mM) were selected since they had low Ki values and do not contain functional groups that are highly reactive with isocyanate. The native substrate, sarcosine (Km=0.6), was not used as a protecting agent since the catalytic oxidation product, hydrogen peroxide, can inactivate the enzyme and can also oxidize the PEG backbone. Modification of sarcosine oxidase at pH 7.5 with either inhibitor showed considerably improved activity retention compared to modification without inhibitor (
Stability of native and PEG-modified sarcosine oxidases were measured at 37° C. in 50 mM phosphate buffer (
Isocyanates are capable of reacting with amino, sulfhydryl, carboxyl, phenolic hydroxyl, imidazole, and phosphate groups in proteins (Means and Feeney, Chemical modification of proteins, San Francisco: Holden-Day, Inc. (1971)); however, only the reaction with amino groups results in the formation of a stable product. Reactions with sulfhydryl, imidazole, tyrosyl, and carboxyl groups give relatively unstable adducts that can decompose upon dilution or change in pH (REF).
Inactivation by cyanate and isocyanate has been reported for a number of enzymes: pepsin (Rimon and Perlmann, J Biol Chem 243: 3566-3572 (1968), papain (Sluyterman, Biochim Biophys Acta 139:439-449 (1967)), trypsin and chymotrypsin (Shaw et al., J Biol Chem 239:PC671-673 (1964); Brown and Wold, Biochemistry 12:835-40 (1973)), and glutathione reductase (Jochheim and Bailie, Biochem Pharmacol 47:1197-1206 (1994)). The proteolytic activity of pepsin was inhibited when tyrosine residues were carbamylated by potassium cyanate; however treatment with hydroxylamine was effective in reversing the inactivation by decarbamylating the residues (Rimon and Perlman, supra, 1968). Papain is also inactivated by cyanate; in fact, the active site thiol of papain is about 3000 times more reactive with cyanate than the thiol group of free cysteine (Sluyterman, supra, 1967). The inactivation is reversible upon dilution due to the lability of the carbamylated sulfhydryl group. Chymotrypsin was also shown to be inactivated by cyanate (Shaw et al., supra, 1964). Modification of the active site serine is the cause of the inactivation and similar effects have been reported for trypsin and subtilisin (Shaw et al., supra, 1964).
In order to determine if sarcosine oxidase modified with isocyanate was modified at a residue giving an unstable adduct (a modified sulfhydryl or tyrosyl residue for example), the enzyme was treated in a number of ways to attempt to reactivate the enzyme activity. Neither dilution, nor dialysis overnight at pH 7.5 was successful in reactivating the enzyme. Treatment with hydroxylamine is a method frequently used to remove weakly bound conjugates from enzymes (Smyth, J. Biol. Chem. 242:1592-1; 598 (1967)). Treatment of isocyanate-modified sarcosine oxidase with hydroxylamine (500 mM, pH 7) for up to 24 hrs was ineffective in reviving the enzyme. Thus, the PEG-isocyantate has reacted with an amine on the surface of the protein and thereby inactivated the enzyme.
In order to determine if inactivation was specific for isocyanate, or whether other amine-modifying PEGs would have a similar effect, sarcosine oxidase was modified using PEG-SPA. PEG-SPA is an NHS-modified PEG that forms stable amide linkages with amines (Hermanson, Bioconjugate Techniques, San Diego: Academic Press, 1996). Interestingly, low modification (average of 1 to 3 PEG's per enzyme) of sarcosine oxidase with PEG-SPA caused a loss of less than 5% activity. At higher modifications (>5 PEG chains attached) more significant loss of enzyme activity was apparent which could be prevented using the inhibitors pyrolecarboxylic and (methylthio)acetic acid. This indicates that the reactivity of PEG-SPA with residues on the surface of sarcosine oxidase is different than the reactivity of PEG-NCO with sarcosine oxidase.
Since modification of sarcosine oxidase at pH 7.5 caused a greater inactivation than at pH 8.5, it seems likely that the modification or the terminal amine can responsible for the loss of activity since the terminal amine should be more reactive (the terminal amine has a lower pKa than the ÿ-amine of lysine). In fact, modification of sarcosine oxidase by PEG-NCO caused no noticeable shift in the visible absorption spectrum of sarcosine oxidase indicating that modification did not occur in the active site. The absorption spectrum of the enzyme-bound FAD of Corynebacterium sarcosine oxidase has been reported to change (red shift of absorption peak from 455 to 462 nm) upon modification of histidine residue with diethylpyrocarbonate (DEP), probably in the vicinity of the flavin moiety, (Hayashi et al., J. Biochem. 94:551-558 (1983)). DEP-modified sarcosine oxidase is completely inactive; however, activity can be recovered by treatment with hydroxylamine. Although the absorption spectrum of Arthrobacter sarcosine oxidase did not shift upon modification with PEG-NCO, this is not absolute evidence that modification did not occur in the active site.
In order to elucidate the effect of chemical modification on sarcosine oxidase activity, computational studies were performed to predict the most important residues for enzyme activity/stability and the most reactive residues for modification.
The reactivity of acetylation on lysine residues in RNAse A as a function of the solvent accessibility (SA) of a residue and the pKa value of lysines has been described previously (Glocker et al., Bioconjugate Chem. 5:583-590 (1994)). Similar results have been shown for deoxy-hemoglobin (Scaloni et al., FEBS Letters 452:190-194 (1999)) and horseradish peroxidase (O'Brien et al., Biotechnol Bioeng 76:277-284 (2001)). Specifically, reactivity increases with increasing SA. However, even with low SA, the reactivity increases dramatically when the pKa of a given lysine residue is especially low (signifying a very good nucleophile). Hence, lysine residues located on the surface of the enzyme (with pKa-10.5) will have a reactivity that is proportional to SA; however, residues located in an environment which can have a significant effect on pKa, like the active site lysine of bovine ribonuclease A, will have a significantly different pKa and altered reactivity.
The predicted pKa's for all lysine residues in sarcosine oxidase (FAD free-MSOX) are shown in Table 1.
LYS 268
2.20
9.68
LYS 322
24.18
13.67
LYS 351
4.76
9.18
The SA was calculated from SWISS PDB viewer and estimated pKa was obtained from the UHBD algorithm. Based on these results, lysine 351 is the most reactive lysine since the pKa of this lysine is 9.18. Lysine 268 in the active site has the second lowest pKa of 9.68. The third active site lysine (lysine 322) has a significantly increased pKa (13.67) and is not suspected to be easily modified.
After finding the optimal conditions for modification of sarcosine oxidase to preserve enzyme activity retention during modification with isocyanate, the enzyme was immobilized in polyurethane hydrogels. Enzyme containing polymers that were prepared with enzyme concentrations of 0 to 200 U/g of polymer had a specific activity that was directly proportional to enzyme concentration (
The immobilized polymers were tested for reusability by repeatedly assaying a single gel sample for eight cycles with no loss of apparent activity (
The thermoinactivation of the enzyme in the polymer was determined by incubating enzyme-polymer samples in buffer at 37° C. and removing samples for assay periodically (
Since the enzyme will be applied to amperometric electrodes that contain silver/AgCl reference electrodes, the effect of silver ions on enzyme activity was explored. Inhibition of enzymes by silver ions from reference electrodes has been noted before (Schaffar, Anal Bioanal Chem 372:254-260 (2002); U.S. Pat. No. 4,547,280) and should be adequately assessed since silver ions can bind very tightly to an enzyme and lead to deactivation.
In order to test sarcosine oxidase for inhibition by silver ions, 1 nM to 1 mM silver nitrate was added to a solution of enzyme and incubated for various amounts of time. The enzyme was then removed from solution and assayed for residual sarcosine oxidase activity in the absence of silver (
This example describes the immobilization and stabilization of creatine amidinohydrolase modified with isocyanate activated polyethylene glycol (PEG).
A. Materials and Protocols Creatine amidinohydrolase (from Actinobacilus sp., CRH-211) and sarcosine oxidase (from Arthrobacter sp., SAO-341) were purchased from Toyobo Co., LTD. All enzymes were used without further purification. PEG-NCO (Mw 5 000) was obtained from Shearwater Polymers Inc. (Huntsville, Ala.). Hypol 2060G prepolymer was purchased from Hampshire Chemical (Lexington, Mass.). All other reagents were purchased from Sigma-Aldrich Chemicals (St. Louis, Mo.) and were of the highest purity available.
PEG-NCO was added at room temperature to a buffered solution (50 mM phosphate, pH 7.5) containing 3 mg/mL creatine amidinohydrolase. The ratio PEG-NCO/Enzyme was adjusted from 0/1 to 100/1. The reaction was mixed for 30 min followed by overnight dialysis against 50 mM phosphate buffer at 4° C. (Drevon et al., Biomacromolecules 2:764-771 (2001)). Enzyme activity following modification was determined using an end point assay (described below).
Hypol prepolymer 2060G (0.4 g), a toluene diisocyanate based prepolymer, was added to a buffered solution (3.6 g of 50 mM phosphate buffer, pH 7.5) containing creatine amidinohydrolase (0 to 100 units enzyme per gram of pre polymer). The aqueous polymer solution was mixed for 30 s in a weigh boat until the onset of gelation. Polymerization was very rapid and gelation was usually complete within one minute.
MALDI-MS analyses were performed using a Perspective Biosystems Voyager Elite MALDI-TOF. The acceleration voltage was set to 20 kV in a linear mode. 1 μL of PEGylated enzyme solution (0.1 mg/mL) was mixed with 1 μL of matrix solution (0.5 mL water, 0.5 mL of acetonitrile, 1 μL of trifluoracetic acid, and 10 mg of sinapinic acid). Spectra were recorded after evaporation of the solvent mixture and were calibrated externally using equine cytochrome C (12,361.96 Da), rabbit muscle aldolase (39,212.28 Da) and bovine serum albumin (66 430.09 Da).
Creatine amidinohydrolase activity was monitored using a colorimetric assay that measures urea formation from the hydrolysis of creatine (Tsuchida and Yoda, Clin. Chem. 29:51-55 (1983)). An enzyme solution (0.1 mL) was incubated with a mixture (0.90 mL) of 100 mM creatine in sodium phosphate buffer (50 mM, pH 7.5) at 37° C. for 10 minutes. The reaction was stopped by adding 2.0 mL of a solution containing Ehrlich's reagent (2.0 g of p-dimethyl aminobenzaldehyde in 100 mL of dimethyl sulfoxide plus 15 mL of concentrated HCl). The solution was incubated for 20 minutes at room temperature and the absorbance at 435 nm was measured. One unit was defined as the amount of enzyme that catalyzes the hydrolysis of 1 μmol of substrate per minute.
The initial rate of oxygen consumption was measured at 37° C. with a Clark oxygen electrode from Yellow Springs Instruments (Yellow Springs, Ohio). The reaction was initiated by adding an enzyme solution (1 μL) or an enzyme-containing polymer (10-100 mg cut into small pieces) to 5.0 mL of substrate (100 mM creatine in 50 mM phosphate buffer, pH 7.5 with at least 6 U/mL sarcosine oxidase). Before measurement the assay solution was allowed to equilibrate to 37° C. with air. Oxygen consumption was measured for 5 to 10 minutes.
Thermoinactivation of native and PEG-creatine amidinohydrolase was monitored at 37° C. in buffer (50 mM sodium phosphate, 2 mM EDTA, pH 7.5). The enzyme concentration in all samples was 0.08 to 0. mg/ml. Samples were removed periodically and assayed for activity using the end point assay.
Enzyme polymer samples were cut into small pieces and added to buffer (50 mM phosphate, pH 7.5) and incubated at 37° C. Samples were removed periodically and assayed for enzymatic activity using the oxygen electrode.
Creatine amidinohydrolase (1.0 mg/mL) was incubated in 20 mM Tris-HCl (pH7.5) with silver nitrate (0 to 1 mM) at room temperature. Samples were removed periodically and assayed using the end point assay. In order to test if creatine acted as a competitive inhibitor for silver inhibition, the end point assay was performed as above with silver nitrate added to the creatine solution (0 to 100 μM AgN03 in 20 mM Tris buffer). After 10 minutes of incubation, the stop solution (p-dimethyl benzaldehyde solution) was added. Control experiments showed silver nitrate had no effect on the color development.
Creatine amidinohydrolase (1.0 mg/ml) was prepared in solution with either 50 mM EDT A, 50 mM EGT A, 50 mM mercaptoethanol, 50 mM DTT or 50 mM cysteine with 20 mM Tris, pH 7.5. Silver nitrate was added to give a final concentration of 0 to 100 μM. After the addition of silver nitrate, the solutions were allowed to incubate for 5 minutes and residual activity was determined using the end point assay.
UV spectra were determined: as described: by Shen et al., J. Inorg. Biochem, 95:124-130 (2003). In short, creatine amidinohydrolase (1 mg/mL) was dissolved in 20 mM Tris (pH 7.5) with varying concentrations of silver nitrate (0-100 μM). In quartz cuvettes, the UV absorption spectra of the enzyme solutions were measured from 230 to 300 nm. Difference spectra were obtained by subtracting the spectrum of the native enzyme (no silver) from the silver-enzyme spectra.
The crystal structure of Actinobacillus creatinase as described by Padmanabhan et al., Acta Crystallogr, Sect. D 58(8): 1322-1328 (2002) (PDB code: 1KP0) was used for Gaussian Network Model (GNM) (Bahar et al., Folding Design 2:173-181 (1997)) analysis of collective dynamics. The CMS (creatine analog) bound A. Bacillus creatinase structure was computationally modeled by combining the CMS molecule in P. putida creatinase structure (PDB code: 1CHM) with the A. Bacillus creatinase structure, followed by standard energy minimization using the MOE package (Molecular Operating Environment, world wide web at chemcomp.com/Corporate_Information/MOE_Bioinformatics.html).
With regard to the effect of chemical modification on creatine amidinohydrolase activity and stability, PEGylation accurately mimics the first steps in polyurethane-based immobilization strategies. Therefore, the enzyme was PEGylated. Creatine amidinohydrolase can be modified with reactive PEG's to a high degree without significant loss of enzyme activity. Modification of each monomer of the enzyme with an average of 5 PEG chains led to loss of only 30% activity.
Although the majority of enzyme activity was retained after modification, a significant decrease in enzyme stability was observed when the modified enzyme was stored in buffer at 37° C. (
Biopolymers were prepared with enzyme concentrations of 0 to 100 units/g of polymer. The specific activity of the enzyme-polymers was directly proportional to enzyme concentration (
The immobilized polymers were tested for reusability by repeatedly assaying a single gel sample for eight cycles with no loss of apparent activity (Table 1). As seen with other polyurethane chemistries, the enzyme is well immobilized within the gel and no leaching of enzyme is observed (Lejeune and Russell, Biotechnol Bioeng 51:450-457 (1996); Lejeune et al., Biotechnol Bioeng 54:105-114 (1997); Drevon et al., Biotechnol Bioeng 79:785-794 (2002)).
The storage stability of the enzyme in the polymer was determined by incubating enzyme-polymer samples in buffer at 37° C. and removing samples periodically to be assayed (
Given that only upon immobilization is the enzyme “locked” into a fixed conformation these data support an intuitive expectation of stability enhancements.
Before being used in a functioning sensor, polyurethane-immobilized enzyme must be applied to amperometric electrodes that contain Ag/AgCl. Given the known propensity of silver ions to interact with proteins (Schaffar, Anal Bioanal Chem 372:254-260 (2002); U.S. Pat. No. 4,547,280), the effect of silver ions on enzyme activity was explored. Silver-induced inactivation becomes more of a concern if a sensor will be used in series with other sensors for a long period of time since the enzyme will have significant time to scavenge silver from solution.
In order to test creatine amidinohydrolase for inhibition by silver ions, the enzyme was incubated with 5-100 μM silver nitrate and assayed for residual creatine amidinohydrolase activity. Silver is a very effective inhibitor of creatine amidinohydrolase completely inhibiting enzyme activity. Furthermore low concentrations of silver effectively inactivate the enzyme; in fact, the silver concentration is on the same order as the enzyme concentration.
In order to determine whether silver was acting as a competitive inhibitor differing concentrations of silver and 90 mM creatine were added to the buffer. The enzyme (˜7 μM) was added directly to this solution and after 10 min the concentration of urea in the system was determined (
Since the enzyme is effectively inhibited by silver ions at concentrations that could be released from electrodes in a clinical biosensor, it is of interest to develop methods to prevent or at least slow enzyme inhibition by silver. Silver can be effectively scavenged by a number of molecules. The use of 50 mM solutions of EDTA, EGTA, DTT, mercaptoethanol, cysteine, imidazole and polyethyleneimine (PEI) was employed to sequester silver. Inhibition by silver ions was effectively prevented by pre-incubation with thiol containing compounds (cysteine, mercaptoethanol, DTT) and prevented somewhat by PEI (
UV/Vis spectroscopy was used to determine if any major structural changes occurred upon binding of silver to the enzyme (
Modification of sulfhydryl groups on creatine amidinohydrolase causes complete loss of activity (Coll et al., J Mol Biol 214:597-610 (1990) and Yoshimoto et al., J Biochem 79:1381-1383 (1976). This is interesting since the Cys residues are all far from the active site and have no known role in catalysis (Coll et al., supra, 1990; Hoeffken et al., J Mol Biol 204:417-433 (1988)). Alkylation of Cys298 inactivates the enzyme even though this residue is far from the active site and the loss of activity can be attributed to the possible prevention of domain motions by alkylation, thus locking the enzyme into a given conformation.
To further investigate how Cys residues, and their interaction with silver ions, might contribute to the function and stability of creatine amidinohydrolase, the dynamics of the protein were examined with the Gaussian Network Model (GNM) (Bahar et al., supra, 1997). The GNM is an elastic network model that has been shown to predict the collective dynamics of proteins, in close agreement with the temperature (B-) factors from X-ray crystallographic experiments (Bahar, Folding Design 2: 13-181 (1997); Kundu et al. Biophys. J. 83: 723-732 (2002)), as well as the free energy costs of H/D exchange (Bahar et al., Biochemistry 37:1067-1075 (1998b)). The approach permits decomposition of the conformational motions into a series of orthogonal modes, ranked by their associated frequencies. The modes with the slowest frequency (the slowest mode), also referred to as the ‘global’ motions, usually reveal the functional movements that engage the entire molecule (Kitao and Go, Curr. Op. Struc. Biol. 9(2):164-169 (1999); Ming et al., Procl. Nat. Acad. Sci. USA 99:8620-8625 (2002); Haliloglu and Bahar, Proteins: Structure, Function and Genetics 37:654-667 (1999); Bahar and Jernigan, J. Mol. Biol. 281:871-884 (1998); Bahar et al., Phys. Rev. Lett. 80:2733-2736 (1998); Bahar et al., J. Mol. Biol. 285:102301037 (1999); Tarna and Sanejouand, Protein Engineering 14:1-6 (2001)). The fastest modes, on the other hand, indicate the ‘local’ motions, and point to individual residues involved in the early folding/stabilization process (Bahar et al. Phys. Rev. Lett. 80:2733-2736 (1998); Rader and Bahar, Polymer 45(2):659-668 (2004). The major utility of the GNM is its efficient applicability to large structures' dynamics (such as creatine amidinohydrolase, a dimer of N=804 residues) that are beyond the range of molecular dynamics simulations.
As a first test, the mean-square fluctuations of creatine amidinohydrolase residues predicted by the GNM were compared with the experimental B factors (Padmanabhan et al., supra, 2002) (
Next, global modes of motions were used to infer information on functional dynamics.
Panel (B) in
The folding nuclei were inferred from the high frequency modes predicted by the GNM. Among the three cysteine residues, Cys297 is distinguished by a peak in
Significantly, silver binds strongly with creatine amidinohydrolase and completely inhibits enzyme function even at low concentrations. As reported in the other papers in this series, all three enzymes needed for the creatinine biosensor are inhibited to some extent by silver; thus, methods for preventing or slowing enzyme inactivation by silver are required.
This example describes the chemical modification and immobilization of the enzyme creatinine amidohydrolase into polyurethane prepolymers.
Creatinine amidohydrolase (from microorganism CNH-311), creatine amidinohydrolase (from Actinobacilus sp., CRH-211) and sarcosine oxidase (from Arthrobacter sp., SAO-341) were purchased from Toyobo Co., LTD. All enzymes were used without further purification. PEG-SPA (Mw 5000) was obtained from Shearwater Polymers Inc. (Huntsville, Ala.). Hypol 20600 prepolymer was purchased from Hampshire Chemical (Lexington, Mass.). All other reagents were purchased from Sigma-Aldrich Chemicals (St. Louis, Mo.) and were of the highest purity available.
PEG-SPA was added at room temperature to a buffered solution (50 mM phosphate, pH 7.5) containing 3 mg/mL creatine amidinohydrolase. The ratio PEG . . . SPA to Enzyme—was adjusted from 0/1 to 100/1. The reaction mixture was mixed for 30 min followed by overnight dialysis (12 000 MWCO) against 50 mM phosphate buffer at 4° C. (Drevon et al., Biomacromolecules 2:764-771 (2001)). Enzyme activity following modification was determined using the end point assay.
Hypol prepolymer 2060G (0.4 g), a toluene diisocyanate based prepolymer, was added to a buffered solution (3.6 g of 50 mM phosphate buffer, pH 7.5) containing creatinine amidohydrolase (0 to 150 units enzyme per gram of prepolymer). The aqueous polymer solution was vigorously mixed for 30 s, using a spatula, in a weigh boat until the onset of gelation. Polymerization was very rapid and gelation was usually complete within one minute.
MALDI-MS analyses were performed using a Perspective Biosystems Voyager Elite MALDI-TOF. The acceleration voltage was set to 20 kV in a linear mode. 1 μL of PEGylated enzyme solution (0.1 mg/mL) was mixed with 1 μL of matrix solution (0. mL water, 0.5 mL of acetonitrile, 1 μL of trifluoracetic acid, and 10 mg of sinapinic acid). Spectra were recorded after evaporation of the solvent mixture and were calibrated externally using equine cytochrome c (12 361.96 Da (ave)), rabbit muscle aldolase (39,212.28 Da (ave)) and bovine serum albumin (66,430.09 Da (ave)).
Measurement of Creatinine Amidohydrolase Activity using an End Point Assay
The measurement of creatinine amidohydrolase activity is based on the Jaffé reaction (Tsuchida and Yoda, Clin. Chem. 29:51-55 (1983)). An enzyme solution (0.1 mL) was incubated with a mixture (0.90 mL) of 100 mM creatine in mM soditim phosphate (pH 7.5) at 37° C. for 10 minutes. After 10 minutes, the creatine/enzyme mixture (0.1 mL) was added to 0.5 M sodium hydroxide (1.9 mL) and 1% picric acid (1.0 mL). This solution was incubated for 20 minutes at room temperature and the absorbance at 520 nm was measured. One unit was defined as the amount of enzyme which catalyzed the formation of 1 μmol of creatinine per minute.
The initial rate of oxygen consumption was measured at 37° C. with a Clark oxygen electrode from Yellow Springs Instruments (Yellow Springs, Ohio). The reaction was initiated by adding an enzyme solution (1 μL) or an enzyme-containing polymer (10-100 mg cut into small pieces) to 5.0 mL of substrate (1.0 mM creatinine in 50 mM phosphate buffer, pH 7.5 with at least 18 U/mL sarcosine oxidase and 10 U/mL creatine amidinohydrolase). Before measurement, the assay solution was allowed to equilibrate to 37° C. with air. Oxygen consumption was measured for 5 to 10 minutes.
Thermoinactivation of native and PEG-creatine amidinohydrolase was monitored at 37° C. in buffer (50 mM sodium phosphate, 2 mM EDTA, pH 7.5). The enzyme concentration in all samples was 0.01 to 0.02 mg/ml. Samples were removed periodically and assayed for activity using the end point assay.
Enzyme polymer samples were cut into small pieces and added to buffer (50 mM phosphate, pH 7.5) and incubated at 37° C. Samples were removed over time and assayed for enzymatic activity using the oxygen electrode.
To determine the effect of silver ions on creatinine amidohydrolase, 57 μg/mL of lyophilized enzyme was incubated in 20 mM Tris-HCl (pH 7.5) with silver nitrate (0 to mM) at room temperature. Samples were removed periodically and assayed using the end point assay.
The relative activities of three-enzyme containing polyurethane membranes were tested by storing membranes (20 mg hydrated) in 1 mL of 50 mM phosphate buffer (pH 5) with (two planar sensors) and without planar sensors in 5 mL Wheaton vials. The membranes were removed and assayed using the oxygen monitor with 1 mM creatinine. The rate of oxygen consumption was measured and the membranes were replaced to be re-assayed the following day. The three enzyme polyurethane membranes were prepared using 1000 units/g prepolymer of sarcosine oxidase and creatine amidinohydrolase and 2500 units/g prepolymer of creatinine amidinohydrolase in 50 mM phophate buffer (pH 7.8) with 50 mM pyrrole-2-carboxylic acid.
Creatinine biosensors were prepared by casting an enzyme-containing polyurethane membrane layer onto an amperometric sensor chip to give a wet polymer thickness of approximately 25 micrometers. Sensor chips were placed into a sensor body and tested using a stop flow setup. Hydrogen peroxide produced from the enzymatic degradation of creatinine was measured amperometrically using a BAS Voltammograph CV-37. Baseline readings were measured using 50 mM phosphate buffer (pH 7.5). The response to 1 mM creatinine was determined by injecting approximately 1 mL of creatinine solution though the sensor body. The increase in amperometric response after 2 minutes was measured. When sensors were not being tested, they were stored at 37° C. in 50 mM phosphate buffer. In order to prevent silver chloride from leaching from the reference electrodes, some sensors were prepared by spotting the electrode surfaces with a cellulose acetate solution (5 wt % in acetone) and were allowed to air dry before application of the enzyme-membrane layer.
In order to determine the effect of chemical modification on creatinine amidohydrolase activity and stability, PEGylation studies were performed. PEG-modifications were made using an NHS ester of PEG (PEG-SPA) at different ratios of PEG-SPA to lyophilized enzyme powder. The enzyme could easily be modified by the PEG-SPA (
The enzyme stability in buffer at 37° C. was observed after modification (
Polymers were prepared with enzyme concentrations of 0 to 150 U/g of polymer and showed a linear increase of specific activity with increase in enzyme concentration (
The immobilized polymers were tested for reusability by repeatedly assaying a single gel sample for eight cycles with no loss of apparent activity (
The thermoinactivation of the enzyme in the polymer was determined by incubating enzyme-polymer samples in buffer at 37° C. and removing samples for assay periodically (
Since the enzyme will be applied to amperometric electrodes that contain Ag/AgCl, the effect of silver ions on enzyme activity was explored. Inhibition of enzymes by silver ions from reference electrodes has been noted before (Schaffar, Anal Bioanal Chem 372:254-260 (2002); U.S. Pat. No. 4,547,280) and should be adequately assessed since silver ions can bind very tightly to the enzyme causing loss in activity. This becomes more of a concern if a sensor will be used in series with other sensors for a long period of time since the enzyme will have significant time to scavenge silver from solution.
In order to test creatinine amidohydrolase for inhibition by silver ions, 1 nM to mM silver nitrate was added to a solution of enzyme (<2.1M) and incubated for various amounts of time. The enzyme was then removed from solution and assayed for residual creatinine amidinohydrolase activity (
In order to test the Stability of the three-enzyme-containing polymer (which would be applied to wafers), three-enzyme polymers were prepared and stored in buffer at 37° C. The enzyme polymers applied to the sensors contained up to 20 times more enzyme than used in the enzyme stability studies. Enzyme-containing polymers were prepared with 1000 units/g prepolymer of sarcosine oxidase and creatine amidinohydrolase and 2500 units/g prepolymer of creatinine amidohydrolase. The enzyme-polymers were removed periodically and assayed for oxygen consumption using an oxygen monitor when the gels were added to 1 mM of creatinine (
When samples of enzyme gels were added to vials containing the amperometric sensor wafers, a faster inactivation occurred (
In order to test the three-enzyme biosensors using the enzyme-polyurethane membranes, amperometric creatinine sensors were prepared by applying enzyme-polymer directly to electrodes of wafers. Sensors were placed into sensor housing and tested for stability using a stop-flow apparatus. When not being tested, sensors were stored at 37° C. (wet). It was found that enzyme-polymers applied directly to the sensor-wafers quickly lost activity (
Since it is apparent that silver leaching from the electrodes can be the cause of inactivation, electrodes were prepared with a cellulose acetate cover membrane over the electrodes. Sensors with the cellulose acetate membranes had considerably improved half-lives (
While the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications, and variations will be apparent to those skilled in the art in light of the foregoing description. Accordingly, it is intended to embrace all such alternatives, modifications, and variations, which fall within the spirit and broad scope of the invention.
To the extent necessary to understand or complete the disclosure of the present invention, all publications, patents, and patent applications mentioned herein are hereby expressly incorporated by reference in their entirety to the same extent as if each were individually so incorporated.
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/US05/35959 | 10/5/2005 | WO | 00 | 4/5/2007 |
| Number | Date | Country | |
|---|---|---|---|
| 60616149 | Oct 2004 | US |
